Literature DB >> 25992422

Extracellular miRNAs: origin, function and biomarkers in hepatic diseases.

Bingcong Zhou, Zhiyang Li, Haowen Yang, Nongyue He.   

Abstract

MicroRNAs (miRNAs), a class of 19-24 nucleotides non-coding RNAs, regulate gene expression by inhibiting both translation and stability of specific mRNAs at the post-transcriptional level. The existence of miRNAs in a series of mammalian body fluids as extracellular nuclease-resistant entities, together with the aberrant expression of miRNAs during the occurrence and development of a wide range of diseases, triggers the possibility that miRNAs as promising noninvasive diagnostic biomarkers are applied to predict the pathological status of the body. However, the origin and biological function of extracellular miRNAs have not been systematically elucidated. In this review, we summarize the current literature on the biogenesis and post-transcriptional regulation of miRNAs, discuss available evidence regarding the possible origin and release of extracellular miRNAs, and collect novel views on their potentials as key mediators in cell-cell communication processes. Finally, we shed light on the accumulating knowledge about their utilities as diagnostic biomarkers in hepatic diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25992422     DOI: 10.1166/jbn.2014.1993

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  6 in total

Review 1.  Applications of Extracellular RNAs in Oncology.

Authors:  Jonathan R Thompson; Jing Zhu; Deepak Kilari; Liang Wang
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

2.  MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer.

Authors:  Jiaqi Wang; Huamao Ye; Dandan Zhang; Yijun Hu; Xiya Yu; Long Wang; Changjing Zuo; Yongwei Yu; Guixia Xu; Shanrong Liu
Journal:  Cancer Cell Int       Date:  2016-02-19       Impact factor: 5.722

3.  Astaxanthin inhibits proliferation and induces apoptosis of LX‑2 cells by regulating the miR‑29b/Bcl‑2 pathway.

Authors:  Shanshan Zhu; Tao Wang; Fei Luo; Huawen Li; Qing Jia; Taiping He; Hongfu Wu; Tangbin Zou
Journal:  Mol Med Rep       Date:  2019-03-14       Impact factor: 2.952

Review 4.  Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease.

Authors:  Zhonghong Yan; Guanran Wang; Xingyang Shi
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

5.  Long noncoding RNA LINC01426 promotes the progression of lung adenocarcinoma via regulating miRNA-125a-5p/ casein kinase 2 alpha 1 axis.

Authors:  Xiaoling Zhu; Jianguo Zhao; Jun Xu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

6.  miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.

Authors:  Yijie Jia; Meiping Guan; Zongji Zheng; Qian Zhang; Chuan Tang; Wenwei Xu; Zhizhou Xiao; Ling Wang; Yaoming Xue
Journal:  J Diabetes Res       Date:  2016-01-28       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.